Here, we demonstrate that cisplatin and nanocurcumin treatment suppressed the JAK/STAT3 pathway and reduced IL-6 expression, suggesting that the JAK/STAT3 pathway mediates the autocrine production of IL-6 in the ovarian cancer model. This evidence concerns the gene IL6 and ovarian cancer.